BNP Paribas Financial Markets Acquires 1,173,872 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

BNP Paribas Financial Markets raised its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 101.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,330,573 shares of the company’s stock after purchasing an additional 1,173,872 shares during the quarter. BNP Paribas Financial Markets’ holdings in ARK Genomic Revolution ETF were worth $67,027,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Perigon Wealth Management LLC grew its stake in shares of ARK Genomic Revolution ETF by 23.5% in the 1st quarter. Perigon Wealth Management LLC now owns 36,528 shares of the company’s stock worth $1,051,000 after acquiring an additional 6,945 shares in the last quarter. SkyOak Wealth LLC grew its stake in shares of ARK Genomic Revolution ETF by 14.2% in the 1st quarter. SkyOak Wealth LLC now owns 8,029 shares of the company’s stock worth $231,000 after acquiring an additional 1,000 shares in the last quarter. Crescent Grove Advisors LLC grew its stake in shares of ARK Genomic Revolution ETF by 9.2% in the 1st quarter. Crescent Grove Advisors LLC now owns 23,794 shares of the company’s stock worth $684,000 after acquiring an additional 2,009 shares in the last quarter. McGuire Investment Group LLC grew its stake in shares of ARK Genomic Revolution ETF by 4.9% in the 1st quarter. McGuire Investment Group LLC now owns 21,558 shares of the company’s stock worth $620,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Sweet Financial Partners LLC grew its stake in shares of ARK Genomic Revolution ETF by 3.1% in the 1st quarter. Sweet Financial Partners LLC now owns 16,500 shares of the company’s stock worth $475,000 after acquiring an additional 500 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of BATS ARKG traded up $0.08 during trading on Friday, hitting $23.24. The stock had a trading volume of 1,852,310 shares. The company’s 50 day moving average price is $24.97 and its two-hundred day moving average price is $27.85.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.